What is the main business of Rezonans Życia?

The main business activity of Rezonans Życia focuses on paramedical activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 3, 2015.

Where is the headquarters located?

The headquarters is located at: ul. Zamiany 15, 02-786 Warszawa.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

The company reported a revenue of $343,801 in 2024, which is an increase of 137.6% compared to 2023.

Is the company profitable?

Yes, in 2024 the company was profitable, achieving a net profit of $30,974, meaning the company increased its profit by 32.1%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $178,449 in 2024, representing 58% of all operating expenses.

Rezonans Życiasp. z o.o.

Paramedical activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2015-12-03

Share capital

5,000.00 PLN

Activity description

Rezonans Życia is the official and exclusive distributor of QUEX devices in Poland, Australia and New Zealand. It offers QUEX S and QUEX ED devices with the OMNIS system for use with people and animals in therapy practices, beauty and wellness salons, and at home, as well as training, technical support and servicing.

Registered address

ul. Zamiany 15/19, 02-786 Warszawa, Poland

Website

rezonans-zycia.pl

Phone

Social media

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 21 days early.

202508/07/2026
202415/07/2025
202314/07/2024
202215/07/2023
202120/06/2022
202014/07/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 469.61kMedianUSD 38.63kAverageUSD 150.37k

Net profit

This companyUSD 57.76kMedianUSD 333.84AverageUSD 12.60k

Operating costs

This companyUSD 401.10kMedianUSD 39.19kAverageUSD 133.48k

Assets

This companyUSD 275.27kMedianUSD 16.85kAverageUSD 103.52k

News

2026-08-16

S enso Quantum Anti-Aging Module

2026-08-16

QUEX and S-ENSO at Beauty Days 2026 – get VIP entry and trade fair discount

2026-07-01

Discover Thousands of QUEX® Possibilities Free series of 2 online webinars | July 2 and 9, 2026 | 7:30 PM

2026-06-12

QUEX ED

2026-01-13

Advanced training for QUEX & SCIO users

Industry

Offer

Biofeedback devices
Bioresonance devices
Biofeedback software
QUEX device modules
Device operation training
Device servicing

Website technology

Online shop

WooCommerce

Website

WordPress

Analytics and marketing

Google Analytics
Meta Pixel

Authorized Representatives

Helena Nieczyporenko – President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Olga Neczyporenkoage 82	10	$135.06	10%
Helena Nieczyporenkoage 57	90	$1,215.56	90%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2016-05-10.

Erste Bank Polska
15 1090 2486 0000 0001 3276 3867

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $20,141.

Grant date	Purpose	Gross amount	Granting body
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$559$559	Prezes Zakładu Ubezpieczeń Społecznych
Jun 1, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$559$559	Prezes Zakładu Ubezpieczeń Społecznych
May 4, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$18,462$18,462	Polski Fundusz Rozwoju S.A.

Competitors

Name	Revenue	Website
Cross Medica Szczepkowscysp. k.	$2,359,440.46	crossmedica2.pl
Visionrsp. z o.o.	$1,069,237.31	visionr.com.pl
Klinika Trychologiisp. z o.o.	$689,220.99	trychologia-slask.pl
Klinika Gorszewskasp. z o.o.	$673,986.87	klinikagorszewska.pl
Pich-Med Groupsp. z o.o.	$535,454.33	pichmed.pl
Rinamedsp. z o.o.	$522,461.37	rinamed.pl
Kandarasp. z o.o.	$452,447.60	kandara.pl
Vigor Pointsp. z o.o.	$300,901.60	vigor-point.pl
Odnowa Medicasp. z o.o.	$238,308.55	odnowamedica.pl
Phtisp. z o.o.	$193,356.82	maksymkomar.com

Change history

Date	Event
2016-07-26	Address change (Ul. Ożynowa 23, 53-009, Wrocław → Ul. Zamiany 15/19, 02-786, Warszawa)
2015-12-03	Entered in the register

FAQ

Last updated: 2026-07-15